Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayJun 06, 2023 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) To Play Key Role in North American Push to Control its Rare Earth Critical Metals Destiny

Canada-based Ucore Rare Metals Inc. is preparing to begin construction on a rare earth element (“REE”) processing plant in Louisiana that it says will be the first REE separation facility to operate at commercial scale in North America Currently, China dominates both REE feedstock supply and REE processing capacity on a global basis, generating concerns that it can control the world’s ability to build modern technologies and use its control to retaliate against countries in adversarial situations Modern technologies that rely on REEs for crucial magnets in their composition include phones, computers, household appliances, electric vehicles, solar panels, and wind…

Continue Reading

MondayJun 05, 2023 12:00 pm

DGE’s 4th Annual Clinical Trial Agreements Forum: Reduce Bottlenecks and Expedite Contracting Timelines

Clinical research, contract specialists, clinical operations, regulatory affairs, and legal strategists will all convene at Dynamic Global Events’ (“DGE’s”) 4th Clinical Trial Agreements Forum, returning to in-person learning on August 29-30 in Philadelphia, PA. As the only industry forum to specifically focus on Clinical Trial Agreements (‘‘CTAs’’), this will be a must-attend for legal, regulatory, and clinical contracting professionals who want to stay ahead of the curve on the latest strategies to overcome the industry’s most pressing challenges. The two-day conference is designed to provide a unique networking and learning experience on the key insights and the latest trends, best…

Continue Reading

MondayJun 05, 2023 11:15 am

Web3 Berlin Conference: Pioneering the Future of Cryptocurrency

Blockchain technology experts, crypto enthusiasts, investors, and business owners are invited to attend the Web3 Berlin Conference to be held in Berlin, Germany, June 10-11, 2023. As the technological world is on the verge of evolution, the much-awaited Web3 Berlin Conference is set to unveil the potential of associated disruptive technologies. Hosting the prominent gathering of unique ideas and intellectual minds, Web3 Berlin Conference promises to celebrate technological innovation. The conference has a rich history of successful events, featuring engaging workshops and immersive panel discussions. The keynote speakers will share insights into blockchain technology, decentralized applications (dApps), decentralized finance (DeFi),…

Continue Reading

MondayJun 05, 2023 10:30 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) Advances Graphite Project with New Technical and Marketing Partnership

Global electrification depends on the availability of graphite to power lithium-ion batteries used in EVs and portable electronic devices The Ruby Graphite Deposit is the only combined graphite flake and vein graphite source in the U.S., Reflex secured the option to acquire a 100% stake in the project in 2022 Reflex engaged Lone Star Tech Minerals to advance Ruby Graphite project, deliverables include a production plan, marketing strategy, customer database, and technical data sheet Biden Administration to award $2.8 billion to expand domestic EV battery manufacturing and graphite processing The worldwide shift to electrification depends on the availability of graphite…

Continue Reading

MondayJun 05, 2023 9:45 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Servicing Underserved and Overlooked Markets Driving a Cashless Society

Digital money is replacing physical cash, and FEXD is developing mobile transaction platforms and services that are helping implement the coming changes in the fintech market FEXD plans to acquire and merge with companies that include country-based fintech pioneers with global scalability, fintech service providers, companies with large customer bases, and more The company is helping ensure humanity has a path forward from archaic and restrictive cash systems – reducing poverty, improving the lives of the unbanked, providing critical financial options for migrant workers, connecting families and communities, empowering charities and women, and educating underprivileged children With plans to offer…

Continue Reading

MondayJun 05, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Animal Study Showing Its Patented DehydraTECH(TM) Technology Significantly Enhances Oral Delivery of Estradiol; Raises $2 Million in Gross Proceeds from Public Offering

Lexaria recently completed its animal study HOR-A22-1 showing its patented DehydraTECH(TM) technology dramatically enhanced the oral delivery of estradiol, a type of estrogen hormone The use of DehydraTECH resulted in ~900% higher peak concentration of estradiol in the bloodstream compared to the control, as well as a 2,000% increase in the levels of estrone Estrone is a type of estrogen that can be reversibly made from estradiol in certain tissues within the female body The study HOR-A22-1 also revealed that DehydraTECH resulted in 1,500% and 12,500% higher exposure to estradiol and estrone over time, respectively, compared to the control Lexaria…

Continue Reading

FridayJun 02, 2023 11:15 am

CISO Global Inc. (NASDAQ: CISO) Provides Essential Protection Against Cybersecurity Threats

Smart organizations are encouraged to meet certain standards and regulations to protect data against cybersecurity threats With more than 15 billion user credentials scattered across the dark web, the threat is real CEO notes that compliance is an important driver for security, and organizations should never view it as a mere technical nuisance Complying with security requirements should be about more than just ticking off mandatory checkboxes, says CISO Global (NASDAQ: CISO) CEO David Jemmett (https://nnw.fm/3bL3c). CISO Global, formerly Cerberus Cyber Sentinel Corp., works closely with companies to provide essential protection, and Jemmett is a recognized expert in the field…

Continue Reading

FridayJun 02, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Displays CDMO Expertise at Prestigious Biomed Israel Conference

Biotechnology innovator BiondVax Pharmaceuticals is dedicated to developing nanosized antibody (NanoAb) treatment BiondVax is also leveraging its team experience in preclinical stage to Phase 3 clinical trial product development to generate new revenues by offering cGMP contract development and manufacturing organization (“CDMO”) services The company recently exhibited its CDMO expertise as well as its NanoAb development pipeline at the 21st annual Biomed Israel conference, which drew over 6,000 attendees from a wide variety of international life sciences disciplines BiondVax’s NanoAb drug candidate pipeline has expanded focus on immune system cytokine targets for treating psoriasis and psoriatic arthritis Israel-based biotechnology company…

Continue Reading

FridayJun 02, 2023 9:45 am

Mullen Automotive Inc. (NASDAQ: MULN) Inks Class 3 Truck PO, Purchase Agreement in Continued Upward Momentum

MULN received an order for one thousand class 3 trucks from its dealer partner, Randy Marion Automotive The company is excited about entering the next phase of its commercial launch with the Mullen THREE Mullen inked a $15 million vehicle purchase agreement with the MGT Lease Company for 250 class 3 cab chassis EV trucks On the heels of several purchase agreements and orders, Mullen Automotive (NASDAQ: MULN) is experiencing impressive momentum as it continues to focus on growing in the electric vehicle space. Most recently, the company received a 1,000-unit purchase order (https://nnw.fm/7S9Cu) and announced a $15.7 million vehicle purchase…

Continue Reading

FridayJun 02, 2023 9:15 am

Genprex Inc.’s (NASDAQ: GNPX) Inspiring Patient Video on Gene Therapy’s Potential in NSCLC Treatment

Gene Therapy's Transformative Potential Highlighted in Inspiring Patient Video Interview with Genprex’s (NASDAQ: GNPX) REQORSA on Benzinga. Click Here for the full article The interview showcases the real-life experience of a patient participating in a clinical trial utilizing Genprex's innovative gene therapy drug candidate, REQORSA, shedding light on the significant impact it could potentially have in advancing the treatment of non-small cell lung cancer. The featured video highlights the compelling story of Jacqueline Marino, a participant in the Phase 1 segment of Genprex's Phase 1/2 Acclaim-1 clinical trial. Marino, diagnosed with non-small cell lung cancer (“NSCLC”), offers an inspiring account…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000